Shionogi & Co., Ltd. (TYO: 4507)
Japan
· Delayed Price · Currency is JPY
2,194.50
+22.50 (1.04%)
Dec 20, 2024, 3:45 PM JST
Shionogi & Revenue
Shionogi & had revenue of 116.38B JPY in the quarter ending September 30, 2024, a decrease of -4.00%. This brings the company's revenue in the last twelve months to 418.51B, down -17.36% year-over-year. In the fiscal year ending March 31, 2024, Shionogi & had annual revenue of 435.08B with 1.97% growth.
Revenue (ttm)
418.51B
Revenue Growth
-17.36%
P/S Ratio
4.49
Revenue / Employee
84.39M
Employees
4,959
Market Cap
1,866.84B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 435.08B | 8.40B | 1.97% |
Mar 31, 2023 | 426.68B | 91.55B | 27.32% |
Mar 31, 2022 | 335.14B | 37.96B | 12.77% |
Mar 31, 2021 | 297.18B | -36.19B | -10.86% |
Mar 31, 2020 | 333.37B | -30.35B | -8.34% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionShionogi & News
- 7 weeks ago - Shionogi & Co., Ltd. (SGIOY) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Antibiotics, an important but tricky business, says Shionogi CEO [Advocacy Lab Content] - EURACTIV.com
- 5 months ago - Shionogi & Co., Ltd. (SGIOY) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 8 months ago - Shionogi & Co., Ltd. and Maze Therapeutics, Inc. Announce Exclusive Worldwide License Agreement for MZE001, a Novel Therapeutic Candidate for the Treatment of Pompe Disease - Business Wire
- 1 year ago - Shionogi & Co., Ltd. (SGIOF) Q2 2023 Earnings Conference Call Transcript - Seeking Alpha
- 1 year ago - Shionogi & Co., Ltd. (SGIOF) Q1 2023 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Shionogi: Likely The Last Viable COVID Play - Seeking Alpha
- 2 years ago - Shionogi & Co., Ltd. (SGIOF) Q3 2022 Earnings Call Transcript - Seeking Alpha